Clopidogrel Versus Cilostazol on Vessels
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06402747
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT06402747
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06402747. Randomized; no masking; primary purpose prevention. Start 2024-04-16 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clopidogrel Versus Cilostazol on Vessels
- Condition
- Type 2 Diabetes
- Condition
- Atherosclerosis
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Cilostazol
- Lead sponsor
- Seoul National University Bundang Hospital
- Collaborator
- Samjin Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct06402747- Content hash
e6b89e9da1dbe847bef8d59a5a2755c73b8b80407b67f644bfc23ddf87caa5ac